The effect of mindfulness on decision-making, inhibitory control, and impulsivity of substance use disorder in-treatment patients: A randomized clinical trial
PLOS ONE · 07.11.2023 · 18 (11) · e0293502
DOI: 10.1371/journal.pone.0293502 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift PLOS ONE, online erschienen am 07.11.2023. Verfasst von Ana Paula Gonçalves Donate und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychobiology, Núcleo de Pesquisa em Saúde e Uso de Substância, Universidade Federal de São Paulo, SP, São Paulo, Brazil. Hauptthemen laut MEDLINE: Mindfulness, Substance-Related Disorders, Gambling. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo.
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
This study aimed to investigate the effects of Mindfulness-Based Relapse Prevention (MBRP) in decision-making, inhibitory control and impulsivity compared to Treatment as Usual (TAU) for individuals with Substance Use Disorders (SUD’s) in Brazil. A randomized clinical trial was conducted with participants from a therapeutic community (n = 122). Decision-making (Iowa Gambling Task), impulsivity dimensions (UPPS-P Scale), and inhibitory control (Stroop Color-Word Test) were assessed before and after the MBRP 8-week intervention. GLM Multivariate analysis was used to evaluate the effects of MBRP on different impulsivity measures. The results showed that MBRP+TAU improved the general decision-making score (p = 0,008) compared to TAU. However, no significant effects were found in impulsivity dimensions and inhibitory control in individuals with SUDs in the therapeutic community. This study found improvement in decision-making in the total IGT score; however, no effect for self-reported impulsivity and inhibitory control among middle-aged patients after an 8-weeks intervention of MBRP protocol in an inpatient setting. It adds information to the subject, with implications and possible directions to be followed by the next clinical trials with patients with SUDs in treatment. Trial registration : EnsaiosClinicos.gov.br : RBR-6c9njc .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Psychobiology, Núcleo de Pesquisa em Saúde e Uso de Substância, Universidade Federal de São Paulo, SP, São Paulo, Brazil.
- Laboratório de Neurociência Cognitiva e Social, Centro de Ciências Biológicas e da Saúde, Universidade Presbiteriana Mackenzie, SP, São Paulo, Brazil.
ORCID-Profile: Emérita Sátiro Opaleye
Förderung
- Fundação de Amparo à Pesquisa do Estado de São Paulo
Zitieren
APA
Donate, A. P. G., de Macedo, E. C., Bedendo, A., Félix Júnior, I., Gallo, G. G., Opaleye, E. S., & Noto, A. R. (2023). The effect of mindfulness on decision-making, inhibitory control, and impulsivity of substance use disorder in-treatment patients: A randomized clinical trial. PLOS ONE, 18(11), e0293502. https://doi.org/10.1371/journal.pone.0293502
Vancouver
Donate APG, de Macedo EC, Bedendo A, Félix Júnior I, Gallo GG, Opaleye ES, et al. The effect of mindfulness on decision-making, inhibitory control, and impulsivity of substance use disorder in-treatment patients: A randomized clinical trial. PLOS ONE. 2023;18(11):e0293502. doi:10.1371/journal.pone.0293502
BibTeX
@article{Donate2023,
author = {Donate, Ana Paula Gonçalves and de Macedo, Elizeu Coutinho and Bedendo, André and Félix Júnior, Itamar and Gallo, Giovanna Gonçalves and Opaleye, Emérita Sátiro and Noto, Ana Regina},
title = {The effect of mindfulness on decision-making, inhibitory control, and impulsivity of substance use disorder in-treatment patients: A randomized clinical trial},
journal = {PLOS ONE},
year = {2023},
volume = {18},
number = {11},
pages = {e0293502},
doi = {10.1371/journal.pone.0293502}
}
EUVIMED